Brain and cardiac MRIs are fundamental noninvasive imaging tools, which can provide
important clinical information and can be performed without or with gadolinium-based …

Gadolinium contrast is an important agent in magnetic resonance imaging (MRI), particularly
in neuroimaging where it can help identify blood–brain barrier breakdown from an …

Background There are concerns over gadolinium deposition from gadolinium‐based
contrast agents (GBCA) administration. Purpose To reduce gadolinium dose in contrast …

Deep learning approaches are playing an ever-increasing role throughout diagnostic
medicine, especially in neuroradiology, to solve a wide range of problems such as …

Patient access to MRI is additionally limited by requirements for exogenous contrast media.
Contrast-enhanced examinations are logistically more complex to perform, and gadolinium …

Contrast media are widely diffused in biomedical imaging, due to their relevance in the
diagnosis of numerous disorders. However, the risk of adverse reactions, the concern of …

Objectives Gadolinium-based contrast agents (GBCAs) have become an integral part in
daily clinical decision making in the last 3 decades. However, there is a broad consensus …

Objectives Artificial intelligence (AI) methods can be applied to enhance contrast in
diagnostic images beyond that attainable with the standard doses of contrast agents (CAs) …

Objectives To evaluate the clinical performance of a deep learning (DL)–based method for
brain MRI exams with reduced gadolinium-based contrast agent (GBCA) dose to provide …

Objectives The purpose of this study was to implement a state-of-the-art convolutional neural
network used to synthesize artificial T1-weighted (T1w) full-dose images from corresponding …